MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

MDT

89.97

+2.2%↑

Search

Alcon Inc

Cerrado

Sector Salud

90.28 0.91

Resumen

Variación precio

24h

Actual

Mínimo

89.69

Máximo

90.31

Métricas clave

By Trading Economics

Ingresos

40M

263M

Ventas

-26M

2.5B

P/B

Media del Sector

38.227

73.394

BPA

0.528

Rentabilidad por dividendo

0.3

Margen de beneficio

10.717

Empleados

25,000

EBITDA

-300M

341M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+12.77 upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.30%

3.09%

Próximas Ganancias

25 feb 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

3.2B

45B

Apertura anterior

89.37

Cierre anterior

90.28

Noticias sobre sentimiento de mercado

By Acuity

61%

39%

335 / 393 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Neutral Evidence

Alcon Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

12 nov 2024, 18:48 UTC

Ganancias
Principales Movimientos del Mercado

Alcon Posts Higher 3Q Sales and Profit, Lowers 2024 Sales View

14 may 2024, 08:28 UTC

Ganancias
Principales Movimientos del Mercado

Alcon's Swiss Shares Jump After Contact-Lense Sales Boost Earnings

17 dic 2024, 15:05 UTC

Charlas de Mercado

Alcon's Late-Stage Pipeline Set To Drive Revenue Growth Next Year -- Market Talk

12 nov 2024, 17:38 UTC

Ganancias

Alcon Narrows 2024 View To Adj EPS $3.00-Adj EPS $3.05 >ALC

12 nov 2024, 17:38 UTC

Ganancias

Alcon Had Seen 2024 Sales $9.9B-$10.1B >ALC

12 nov 2024, 17:37 UTC

Ganancias

Alcon Cuts 2024 View To Sales $9.8B-$9.9B >ALC

12 nov 2024, 17:36 UTC

Ganancias

Alcon 3Q Core Operating Margin 20.6% >ALC

12 nov 2024, 17:36 UTC

Ganancias

Alcon 3Q Sales $2.43B >ALC

12 nov 2024, 17:36 UTC

Ganancias

Alcon 3Q Adj EPS 81c >ALC

12 nov 2024, 17:35 UTC

Ganancias

Alcon 3Q EPS 53c >ALC

12 nov 2024, 17:35 UTC

Ganancias

Alcon 3Q Rev $2.45B >ALC

21 ago 2024, 07:01 UTC

Charlas de Mercado
Ganancias

Alcon's Transformation Is Paying Off -- Market Talk

20 ago 2024, 20:36 UTC

Ganancias

Alcon 2Q Sales $2.482B >ALC.EB

20 ago 2024, 20:36 UTC

Ganancias

Alcon Sees 2024 Sales $9.9B-$10.1B >ALC.EB

20 ago 2024, 20:36 UTC

Ganancias

Alcon 2Q EPS 45c >ALC.EB

14 may 2024, 07:44 UTC

Charlas de Mercado
Ganancias

Alcon's Results Reduce Risk for Full Year -- Market Talk

13 may 2024, 20:33 UTC

Ganancias

Alcon Backs 2024 Sales $9.9B-$10.1B >ALC.EB

13 may 2024, 20:33 UTC

Ganancias

Alcon 1Q EPS 50c >ALC.EB

13 may 2024, 20:33 UTC

Ganancias

Alcon 1Q Sales $2.4B >ALC.EB

13 may 2024, 20:32 UTC

Ganancias

Alcon 1Q Rev $2.4B >ALC.EB

13 may 2024, 20:32 UTC

Ganancias

Alcon 1Q EPS 50c >ALC.EB

27 feb 2024, 21:34 UTC

Ganancias

Alcon Sees 2024 Sales $9.9B-$10.1B >ALC.EB

27 feb 2024, 21:33 UTC

Ganancias

Alcon 4Q EPS 86c >ALC.EB

27 feb 2024, 21:32 UTC

Ganancias

Alcon 4Q Rev $2.35B >ALC.EB

Comparación entre iguales

Cambio de precio

Alcon Inc Esperado

Precio Objetivo

By TipRanks

12.77% repunte

Estimación a 12 meses

Media 101.01 USD  12.77%

Máximo 106 USD

Mínimo 85 USD

De acuerdo con 10 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Alcon Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

10 ratings

8

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

89.415 / 90.38Soporte y Resistencia

Corto Plazo

Neutral Evidence

Medio plazo

Neutral Evidence

Largo Plazo

Weak Bullish Evidence

Sentimiento

By Acuity

335 / 393 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.